{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:29:59Z","timestamp":1780432199748,"version":"3.54.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.intimp.2024.112536","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T11:50:32Z","timestamp":1719057032000},"page":"112536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Apilarnil exerts neuroprotective effects and alleviates motor dysfunction by rebalancing M1\/M2 microglia polarization, regulating miR-155 and miR-124 expression in a rotenone-induced Parkinson\u2019s disease rat model"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1873-6222","authenticated-orcid":false,"given":"Rania M.","family":"Salama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4238-7069","authenticated-orcid":false,"given":"Samar F.","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Yehia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermin","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noura F.","family":"Elmongy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8837-5717","authenticated-orcid":false,"given":"Mona M.","family":"Abd-Elgalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona F.","family":"Schaalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A.","family":"El Wakeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2024.112536_b0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","article-title":"The Parkinson pandemic-a call to action","volume":"75","author":"Dorsey","year":"2018","journal-title":"JAMA. Neurol."},{"issue":"9996","key":"10.1016\/j.intimp.2024.112536_b0010","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.112536_b0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia function in the central nervous system during health and neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. Rev. Immunol"},{"issue":"12","key":"10.1016\/j.intimp.2024.112536_b0020","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1007\/s10072-020-04468-5","article-title":"The role of microglia in the development of neurodegeneration","volume":"41","author":"Saitgareeva","year":"2020","journal-title":"Neurol. Sci"},{"key":"10.1016\/j.intimp.2024.112536_b0025","doi-asserted-by":"crossref","first-page":"1103416","DOI":"10.3389\/fneur.2023.1103416","article-title":"Microglia activation in central nervous system disorders: A review of recent mechanistic investigations and development efforts","volume":"14","author":"Qin","year":"2023","journal-title":"Front. Neurol"},{"issue":"4","key":"10.1016\/j.intimp.2024.112536_b0030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/bph.13139","article-title":"Microglial M1\/M2 polarization and metabolic states","volume":"173","author":"Orihuela","year":"2016","journal-title":"Br. J. Pharmacol"},{"issue":"7","key":"10.1016\/j.intimp.2024.112536_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/cells12071012","article-title":"Microglia mediated neuroinflammation in Parkinson's disease","volume":"12","author":"Isik","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.intimp.2024.112536_b0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal. Transduct. Target. Ther"},{"key":"10.1016\/j.intimp.2024.112536_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115653","article-title":"Quercetin improves cerebral ischemia\/reperfusion injury by promoting microglia\/macrophages M2 polarization via regulating PI3K\/Akt\/NF-kappaB signaling pathway","volume":"168","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother"},{"key":"10.1016\/j.intimp.2024.112536_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578180","article-title":"Microglia mediated neuroinflammation in neurodegenerative diseases: A review on the cell signaling pathways involved in microglial activation","volume":"383","author":"Biswas","year":"2023","journal-title":"J. Neuroimmunol"},{"issue":"2","key":"10.1016\/j.intimp.2024.112536_b0055","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/hipo.23491","article-title":"miRNA-124 alleviated memory impairment induced by d-galactose rapidly in male rats via microglia polarization","volume":"33","author":"Huang","year":"2023","journal-title":"Hippocampus"},{"issue":"8","key":"10.1016\/j.intimp.2024.112536_b0060","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1523\/JNEUROSCI.3900-15.2016","article-title":"microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease","volume":"36","author":"Thome","year":"2016","journal-title":"J. Neurosci"},{"issue":"3","key":"10.1016\/j.intimp.2024.112536_b0065","first-page":"355","article-title":"Apilarnil reduces fear and advances sexual development in male broilers but has no effect on growth","volume":"54","author":"Altan","year":"2013","journal-title":"Br. Poult. Sci"},{"key":"10.1016\/j.intimp.2024.112536_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119875","article-title":"Nephroprotective effect of apilarnil in lipopolysaccharide-induced sepsis through TLR4\/NF-kappaB signaling pathway","volume":"284","author":"Inandiklioglu","year":"2021","journal-title":"Life. Sci"},{"key":"10.1016\/j.intimp.2024.112536_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109967","article-title":"Investigation of protective effects of apilarnil against lipopolysaccharide induced liver injury in rats via TLR 4\/ HMGB-1\/ NF-kappaB pathway","volume":"125","author":"Doganyigit","year":"2020","journal-title":"Biomed. Pharmacother"},{"issue":"2","key":"10.1016\/j.intimp.2024.112536_b0080","first-page":"14","article-title":"Chemical content and bioactive properties of drone larvae (Apilarnil)","volume":"19","author":"Si\u0307li\u0307ci\u0307","year":"2019","journal-title":"Mellifera"},{"issue":"2","key":"10.1016\/j.intimp.2024.112536_b0085","first-page":"33","article-title":"Apilarnil: a novel neuroprotective candidate","volume":"29","author":"Hamamci","year":"2020","journal-title":"Acta. Neurologica. Taiwanica"},{"key":"10.1016\/j.intimp.2024.112536_b0090","unstructured":"N.R. Council, D.E.L. Studies, I.L.A. Research, C.U.G.C.U.L. Animals, Guide for the Care and Use of Laboratory Animals: Eighth Edition, National Academies Press, 2010."},{"issue":"7","key":"10.1016\/j.intimp.2024.112536_b0095","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1007\/s12035-016-0028-7","article-title":"Tetramethylpyrazine ameliorates rotenone-induced Parkinson's disease in rats: involvement of its anti-inflammatory and anti-apoptotic actions","volume":"54","author":"Michel","year":"2017","journal-title":"Mol. Neurobiol"},{"key":"10.1016\/j.intimp.2024.112536_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115853","article-title":"Neuroprotective effects of indole-3-carbinol on the rotenone rat model of Parkinson's disease: Impact of the SIRT1-AMPK signaling pathway","volume":"435","author":"Mohamad","year":"2022","journal-title":"Toxicol. Appl. Pharmacol"},{"key":"10.1016\/j.intimp.2024.112536_b0105","doi-asserted-by":"crossref","unstructured":"M. Ala, R. Mohammad Jafari, H. Nematian, M.R. Ganjedanesh, A. Naderi, M. Akbariani, M. Sanatkar, L. Satarian, M. Aghsaei Fard, A.R. Dehpour, Neuroprotective Effect of Intravitreal Single-Dose Lithium Chloride after Optic Nerve Injury in Rats, Curr. Eye Res. 46(4) (2021) 558-567. Doi: 10.1080\/02713683.2020.1808999.","DOI":"10.1080\/02713683.2020.1808999"},{"issue":"5","key":"10.1016\/j.intimp.2024.112536_b0110","first-page":"254","article-title":"Preclinical safety pharmacological studies on the amorphous formulation of celecoxib","volume":"59","author":"Sharma","year":"2009","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.intimp.2024.112536_b0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2016.08.003","article-title":"Edaravone alleviates cisplatin-induced neurobehavioral deficits via modulation of oxidative stress and inflammatory mediators in the rat hippocampus","volume":"791","author":"Jangra","year":"2016","journal-title":"Eur. J. Pharmacol"},{"issue":"8","key":"10.1016\/j.intimp.2024.112536_b0120","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1002\/jcp.26412","article-title":"Potential neuroprotective effect of androst-5-ene-3beta, 17beta-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model","volume":"233","author":"Salama","year":"2018","journal-title":"J. Cell. Physiol"},{"key":"10.1016\/j.intimp.2024.112536_b0125","series-title":"Bancroft's Theory and Practice of Histological Techniques E-Book","author":"Suvarna","year":"2018"},{"key":"10.1016\/j.intimp.2024.112536_b0130","doi-asserted-by":"crossref","unstructured":"H. Fikry, L.A. Saleh, S. Abdel Gawad, Neuroprotective effects of curcumin on the cerebellum in a rotenone-induced Parkinson's Disease Model, CNS Neurosci. Ther. 28(5) (2022) 732-748. Doi: 10.1111\/cns.13805.","DOI":"10.1111\/cns.13805"},{"issue":"3","key":"10.1016\/j.intimp.2024.112536_b0135","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10787-022-00956-6","article-title":"Neuroprotective effect of liraglutide in an experimental mouse model of multiple sclerosis: role of AMPK\/SIRT1 signaling and NLRP3 inflammasome","volume":"30","author":"Ammar","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.intimp.2024.112536_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114917","article-title":"Betanin improves motor function and alleviates experimental Parkinsonism via downregulation of TLR4\/MyD88\/NF-kappaB pathway: Molecular docking and biological investigations","volume":"164","author":"ElSayed","year":"2023","journal-title":"Biomed. Pharmacother"},{"issue":"1","key":"10.1016\/j.intimp.2024.112536_b0145","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12974-020-02023-9","article-title":"Substantia nigra Smad3 signaling deficiency: relevance to aging and Parkinson's disease and roles of microglia, proinflammatory factors, and MAPK","volume":"17","author":"Liu","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"7","key":"10.1016\/j.intimp.2024.112536_b0150","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00406-020-01107-0","article-title":"Lateralization of increased density of Iba1-immunopositive microglial cells in the anterior midcingulate cortex of schizophrenia and bipolar disorder","volume":"270","author":"Petrasch-Parwez","year":"2020","journal-title":"Eur. Arch. Psychiatry. Clin. Neurosci"},{"issue":"2","key":"10.1016\/j.intimp.2024.112536_b0155","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson's disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol. Dis"},{"key":"10.1016\/j.intimp.2024.112536_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107900","article-title":"Neuroprotective effect of crocin against rotenone-induced Parkinson's disease in rats: Interplay between PI3K\/Akt\/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221","volume":"164","author":"Salama","year":"2020","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.intimp.2024.112536_b0165","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2\u2212\u0394\u0394CT Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.intimp.2024.112536_b0170","doi-asserted-by":"crossref","first-page":"1231706","DOI":"10.3389\/fragi.2023.1231706","article-title":"The dual face of microglia (M1\/M2) as a potential target in the protective effect of nutraceuticals against neurodegenerative diseases","volume":"4","author":"Darwish","year":"2023","journal-title":"Front. Aging"},{"key":"10.1016\/j.intimp.2024.112536_b0175","doi-asserted-by":"crossref","first-page":"1213393","DOI":"10.1155\/2022\/1213393","article-title":"Neuropsychiatric Symptoms in Clinically Defined Parkinson\u2019s Disease: An Updated Review of Literature","volume":"2022","author":"Mac\u00edas-Garc\u00eda","year":"2022","journal-title":"Behavioural. Neurology"},{"issue":"10","key":"10.1016\/j.intimp.2024.112536_b0180","article-title":"Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson's Disease","volume":"9","author":"Prasad","year":"2020","journal-title":"Antioxidants. (basel)"},{"issue":"9","key":"10.1016\/j.intimp.2024.112536_b0185","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/mds.29510","article-title":"Nigral Pathology Contributes to Microstructural Integrity of Striatal and Frontal Tracts in Parkinson's Disease","volume":"38","author":"Lin","year":"2023","journal-title":"Mov. Disord"},{"key":"10.1016\/j.intimp.2024.112536_b0190","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.861094","article-title":"Revisiting preclinical observations of several histamine H3 receptor antagonists\/inverse agonists in cognitive impairment, anxiety, depression, and sleep-wake cycle disorder","volume":"13","author":"Alhusaini","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112536_b0195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroimage.2018.11.021","article-title":"The role of dopamine in the brain - lessons learned from Parkinson's disease","volume":"190","author":"Meder","year":"2019","journal-title":"NeuroImage"},{"issue":"1","key":"10.1016\/j.intimp.2024.112536_b0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s10020-021-00279-2","article-title":"Novel targeted therapies for Parkinson's disease","volume":"27","author":"Ntetsika","year":"2021","journal-title":"Mol. Med"},{"key":"10.1016\/j.intimp.2024.112536_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2022.05.037","article-title":"Suppression of abnormal \u03b1-synuclein expression by activation of BDNF transcription ameliorates Parkinson's disease-like pathology","volume":"29","author":"Cao","year":"2022","journal-title":"Mol. Ther. Nucleic. Acids"},{"issue":"1","key":"10.1016\/j.intimp.2024.112536_b0210","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40035-023-00378-6","article-title":"Role of dopamine in the pathophysiology of Parkinson's disease","volume":"12","author":"Zhou","year":"2023","journal-title":"Transl. Neurodegener"},{"issue":"s2","key":"10.1016\/j.intimp.2024.112536_b0215","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.3233\/JPD-212724","article-title":"An update on gene therapy approaches for Parkinson's disease: restoration of dopaminergic function","volume":"11","author":"Van Laar","year":"2021","journal-title":"J. Parkinsons. Dis"},{"issue":"1","key":"10.1016\/j.intimp.2024.112536_b0220","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-023-00622-7","article-title":"Neuropathology of incidental Lewy body & prodromal Parkinson's disease","volume":"18","author":"Koeglsperger","year":"2023","journal-title":"Mol. Neurodegener"},{"issue":"8","key":"10.1016\/j.intimp.2024.112536_b0225","article-title":"Astrocytic oxidative\/nitrosative stress contributes to Parkinson's disease pathogenesis: the dual role of reactive astrocytes","volume":"8","author":"Rizor","year":"2019","journal-title":"Antioxidants. (basel)"},{"issue":"1","key":"10.1016\/j.intimp.2024.112536_b0230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41531-023-00447-7","article-title":"Plasma GFAP in Parkinson\u2019s disease with cognitive impairment and its potential to predict conversion to dementia","volume":"9","author":"Tang","year":"2023","journal-title":"Npj. Parkinson's. Disease"},{"issue":"12","key":"10.1016\/j.intimp.2024.112536_b0235","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.3390\/biomedicines10123174","article-title":"Systemic Rotenone Administration Causes Extra-Nigral Alterations in C57BL\/6 Mice","volume":"10","author":"Thomas Broome","year":"2022","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.intimp.2024.112536_b0240","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/cns.13805","article-title":"Neuroprotective effects of curcumin on the cerebellum in a rotenone-induced Parkinson\u2019s disease Model","volume":"28","author":"Fikry","year":"2022","journal-title":"CNS Neurosci. Therapeutics"},{"issue":"6","key":"10.1016\/j.intimp.2024.112536_b0245","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","article-title":"The role of astrocyte dysfunction in Parkinson\u2019s disease pathogenesis","volume":"40","author":"Booth","year":"2017","journal-title":"Trends. Neurosci."},{"issue":"3","key":"10.1016\/j.intimp.2024.112536_b0250","doi-asserted-by":"crossref","first-page":"664","DOI":"10.14336\/AD.2018.0720","article-title":"Reactive Astrocytes in Neurodegenerative Diseases","volume":"10","author":"Li","year":"2019","journal-title":"Aging Dis."},{"issue":"6","key":"10.1016\/j.intimp.2024.112536_b0255","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020628","article-title":"Astrocytes in neurodegenerative disease","volume":"7","author":"Phatnani","year":"2015","journal-title":"Cold Spring. Harb. Perspect. Biol"},{"key":"10.1016\/j.intimp.2024.112536_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174573","article-title":"The potential neuroprotective effect of diosmin in rotenone-induced model of Parkinson's disease in rats","volume":"914","author":"Habib","year":"2022","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.intimp.2024.112536_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134652","article-title":"Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease","volume":"716","author":"Parkhe","year":"2020","journal-title":"Neurosci. Lett"},{"issue":"9","key":"10.1016\/j.intimp.2024.112536_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092236","article-title":"Beyond Activation: Characterizing Microglial Functional Phenotypes","volume":"10","author":"Lier","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.intimp.2024.112536_b0275","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12974-020-02065-z","article-title":"Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson's disease model","volume":"18","author":"Zhang","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2024.112536_b0280","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3389\/fphar.2020.00420","article-title":"Precision dosing priority criteria: drug, disease, and patient population variables","volume":"11","author":"Tyson","year":"2020","journal-title":"Front. Pharmacol"},{"issue":"7","key":"10.1016\/j.intimp.2024.112536_b0285","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.4103\/1673-5374.360264","article-title":"Molecular mechanisms underlying the neuroprotection of environmental enrichment in Parkinson's disease","volume":"18","author":"Alarc\u00f3n","year":"2023","journal-title":"Neural. Regen. Res"},{"issue":"1","key":"10.1016\/j.intimp.2024.112536_b0290","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11064-008-9656-2","article-title":"Oxidative and inflammatory pathways in Parkinson's disease","volume":"34","author":"Miller","year":"2009","journal-title":"Neurochem. Res"},{"issue":"4","key":"10.1016\/j.intimp.2024.112536_b0295","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41593-018-0090-8","article-title":"Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion","volume":"21","author":"Huang","year":"2018","journal-title":"Nat. Neurosci"},{"issue":"3","key":"10.1016\/j.intimp.2024.112536_b0300","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4103\/1673-5374.380821","article-title":"Role of CD36 in central nervous system diseases","volume":"19","author":"Feng","year":"2024","journal-title":"Neural. Regenerat. Res."},{"key":"10.1016\/j.intimp.2024.112536_b0305","doi-asserted-by":"crossref","unstructured":"D. Michlmayr, C.S. McKimmie, Role of CXCL10 in central nervous system inflammation, Int. J. Interferon, Cytokine Mediat. Res. (2014) 1-18. Doi: 10.2147\/IJICMR.S35953.","DOI":"10.2147\/IJICMR.S35953"},{"key":"10.1016\/j.intimp.2024.112536_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134533","article-title":"Regulation of CNS precursor function by neuronal chemokines","volume":"715","author":"Watson","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.intimp.2024.112536_b0315","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00198","article-title":"Overview of general and discriminating markers of differential microglia phenotypes","volume":"14","author":"Jurga","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.intimp.2024.112536_b0320","doi-asserted-by":"crossref","unstructured":"F.O. Martinez, S. Gordon, The M1 and M2 paradigm of macrophage activation: time for reassessment, F1000Prime Rep 6 (2014) 13. Doi: 10.12703\/p6-13.","DOI":"10.12703\/P6-13"},{"key":"10.1016\/j.intimp.2024.112536_b0325","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.815347","article-title":"Microglia polarization from M1 to M2 in neurodegenerative diseases","volume":"14","author":"Guo","year":"2022","journal-title":"Front. Aging. Neurosci"},{"key":"10.1016\/j.intimp.2024.112536_b0330","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fnagi.2017.00148","article-title":"Role of atypical chemokine receptors in microglial activation and polarization","volume":"9","author":"Salvi","year":"2017","journal-title":"Front. Aging. Neurosci"},{"key":"10.1016\/j.intimp.2024.112536_b0335","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.semcdb.2019.05.004","article-title":"Microglia-mediated neuroinflammation in neurodegenerative diseases","volume":"94","author":"Subhramanyam","year":"2019","journal-title":"Semin. Cell. Dev. Biol"},{"key":"10.1016\/j.intimp.2024.112536_b0340","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.679034","article-title":"Glial cell line-derived neurotrophic factor family ligands, players at the interface of neuroinflammation and neuroprotection: focus onto the glia","volume":"15","author":"Kotliarova","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"9","key":"10.1016\/j.intimp.2024.112536_b0345","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/nn.4085","article-title":"Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD\/ALS","volume":"18","author":"Jovi\u010di\u0107","year":"2015","journal-title":"Nat. Neurosci"},{"key":"10.1016\/j.intimp.2024.112536_b0350","article-title":"Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson\u2019s disease","author":"Mohammed","year":"2023","journal-title":"Pathology-Res. Pract."},{"issue":"1","key":"10.1016\/j.intimp.2024.112536_b0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2012.12.009","article-title":"Regulation of the MIR155 host gene in physiological and pathological processes","volume":"532","author":"Elton","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.intimp.2024.112536_b0360","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.744942","article-title":"MicroRNAs Play a Role in Parkinson\u2019s disease by regulating microglia function: from pathogenetic involvement to therapeutic potential","volume":"14","author":"Li","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2024.112536_b0365","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/ijms23010090","article-title":"MiR-155: an important regulator of Neuroinflammation","volume":"23","author":"Zingale","year":"2021","journal-title":"Int. J. Mol. Sci"},{"issue":"1","key":"10.1016\/j.intimp.2024.112536_b0370","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41467-017-00972-z","article-title":"An NF-kappaB-microRNA regulatory network tunes macrophage inflammatory responses","volume":"8","author":"Mann","year":"2017","journal-title":"Nat. Commun"},{"issue":"6","key":"10.1016\/j.intimp.2024.112536_b0375","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbadis.2009.02.013","article-title":"miR-155 gene: a typical multifunctional microRNA","volume":"1792","author":"Faraoni","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2024.112536_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104515","article-title":"miR-124 and Parkinson\u2019s disease: A biomarker with therapeutic potential","volume":"150","author":"Angelopoulou","year":"2019","journal-title":"Pharmacological. Research"},{"issue":"9","key":"10.1016\/j.intimp.2024.112536_b0385","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/acn3.51146","article-title":"Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients","volume":"7","author":"Ravanidis","year":"2020","journal-title":"Annals. Clin. Translat. Neurol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924010579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924010579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T15:39:23Z","timestamp":1720280363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924010579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":77,"alternative-id":["S1567576924010579"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112536","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apilarnil exerts neuroprotective effects and alleviates motor dysfunction by rebalancing M1\/M2 microglia polarization, regulating miR-155 and miR-124 expression in a rotenone-induced Parkinson\u2019s disease rat model","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112536"}}